| Code | 7821B | ||||||||||
| MA number | EU/1/15/1064/002 | ||||||||||
| Product Form: | sol inj 1x1 ml/10e8 PFU (liek.inj.cykloolefín.polymér) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Amgen Europe B.V., Netherland | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | vial | ||||||||||
| Route of admin.: | Intralesional use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 16.12.2015 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 04.09.2024 |
